Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Options in Hereditary Optic Neuropathies
Giulia Amore, Martina Romagnoli, Michele Carbonelli, et al.
Drugs (2020) Vol. 81, Iss. 1, pp. 57-86
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Revitalizing Ancient Mitochondria with Nano‐Strategies: Mitochondria‐Remedying Nanodrugs Concentrate on Disease Control
Xingyu Long, Min Liu, Yayun Nan, et al.
Advanced Materials (2024) Vol. 36, Iss. 18
Closed Access | Times Cited: 29
Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial
Patrick Yu‐Wai‐Man, Valério Carelli, Nancy J. Newman, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101437-101437
Open Access | Times Cited: 17
Mitochondrial diseases: from molecular mechanisms to therapeutic advances
Hu Wen, Hui Deng, Bingyan Li, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Role of Oxidative Stress in Ocular Diseases Associated with Retinal Ganglion Cells Degeneration
Eugene Yu‐Chuan Kang, Pei‐Kang Liu, Yao‐Tseng Wen, et al.
Antioxidants (2021) Vol. 10, Iss. 12, pp. 1948-1948
Open Access | Times Cited: 62
Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: towards improved diagnosis and management
Nancy J. Newman, Patrick Yu‐Wai‐Man, Valérie Biousse, et al.
The Lancet Neurology (2022) Vol. 22, Iss. 2, pp. 172-188
Open Access | Times Cited: 57
Pathological mitophagy disrupts mitochondrial homeostasis in Leber’s hereditary optic neuropathy
Alberto Danese, Simone Patergnani, Alessandra Maresca, et al.
Cell Reports (2022) Vol. 40, Iss. 3, pp. 111124-111124
Open Access | Times Cited: 47
Oxidative Stress: A Suitable Therapeutic Target for Optic Nerve Diseases?
Francesco Buonfiglio, Elsa Wilma Böhm, Norbert Pfeiffer, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1465-1465
Open Access | Times Cited: 26
Genetic variants affecting NQO1 protein levels impact the efficacy of idebenone treatment in Leber hereditary optic neuropathy
Serena J. Aleo, Valentina Del Dotto, Martina Romagnoli, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101383-101383
Open Access | Times Cited: 15
Precise subcellular targeting approaches for organelle-related disorders
Gayong Shim, Yu Seok Youn
Advanced Drug Delivery Reviews (2024) Vol. 212, pp. 115411-115411
Closed Access | Times Cited: 10
Leber’s hereditary optic neuropathy – current status of idebenone and gene replacement therapies
Thomas Klopstock, Li Zeng, Claudia Priglinger
Medizinische Genetik (2025) Vol. 37, Iss. 1, pp. 57-63
Closed Access | Times Cited: 1
Mitochondrial optic neuropathies
Valério Carelli, Chiara La Morgia, Patrick Yu‐Wai‐Man
Handbook of clinical neurology (2023), pp. 23-42
Closed Access | Times Cited: 22
Advanced gene therapy system for the treatment of solid tumour: A review
Yuhan Ma, Juan Liao, Hongxia Cheng, et al.
Materials Today Bio (2024) Vol. 27, pp. 101138-101138
Open Access | Times Cited: 7
Common methods in mitochondrial research (Review)
Yiyuan Yin, Haitao Shen
International Journal of Molecular Medicine (2022) Vol. 50, Iss. 4
Open Access | Times Cited: 26
Neuroprotection in neurodegenerations of the brain and eye: Lessons from the past and directions for the future
Leonard A. Levin, Christopher Patrick, Nozhat Choudry, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 25
Optic nerve diseases and regeneration: How far are we from the promised land?
Ling‐Ping Cen, Kevin K. Park, Kwok‐Fai So
Clinical and Experimental Ophthalmology (2023) Vol. 51, Iss. 6, pp. 627-641
Open Access | Times Cited: 15
Challenges and opportunities to bridge translational to clinical research for personalized mitochondrial medicine
Andrea Gropman, Martine Uittenbogaard, Anne Chiaramello
Neurotherapeutics (2024) Vol. 21, Iss. 1, pp. e00311-e00311
Open Access | Times Cited: 5
Pathogenic mitochondrial dysfunction and metabolic abnormalities
Walter H. Moos, Douglas V. Faller, Ioannis P. Glavas, et al.
Biochemical Pharmacology (2021) Vol. 193, pp. 114809-114809
Open Access | Times Cited: 31
Developments in the Treatment of Leber Hereditary Optic Neuropathy
Benson Chen, Patrick Yu‐Wai‐Man, Nancy J. Newman
Current Neurology and Neuroscience Reports (2022) Vol. 22, Iss. 12, pp. 881-892
Open Access | Times Cited: 22
DNAJC30 disease-causing gene variants in a large Central European cohort of patients with suspected Leber’s hereditary optic neuropathy and optic atrophy
Sinja Kieninger, Ting Xiao, Nicole Weisschuh, et al.
Journal of Medical Genetics (2022) Vol. 59, Iss. 10, pp. 1027-1034
Open Access | Times Cited: 21
A challenging differential diagnosis - Leber’s Hereditary Optic Neuropathy
Raluca Eugenia Iorga, Răzvana Sorina Munteanu-Dănulescu, Ciprian Danielescu
Romanian Journal of Ophthalmology (2024) Vol. 68, Iss. 1
Open Access | Times Cited: 3
Idebenone improves mitochondrial respiratory activity and attenuates oxidative damage via the SIRT3-SOD2 pathway in a prion disease cell model
Zhixin Sun, Pei Wen, Dongming Yang, et al.
Life Sciences (2025) Vol. 366-367, pp. 123481-123481
Closed Access
Cell Replacement Therapy for Retinal and Optic Nerve Diseases: Cell Sources, Clinical Trials and Challenges
Rosa M. Coco, Salvador Pastor‐Idoate, José Carlos Pastor Jimeno
Pharmaceutics (2021) Vol. 13, Iss. 6, pp. 865-865
Open Access | Times Cited: 22
Therapeutic landscape for inherited ocular diseases: current and emerging therapies
HweiWuen Chan, Jaslyn Oh, Bart P. Leroy
Singapore Medical Journal (2023) Vol. 64, Iss. 1, pp. 17-26
Open Access | Times Cited: 9
Omega-3 fatty acids promote neuroprotection, decreased apoptosis and reduced glial cell activation in the retina of a mouse model of OPA1-related autosomal dominant optic atrophy
Maria Kalogerou, Sotiris Ioannou, Panagiotis Kolovos, et al.
Experimental Eye Research (2021) Vol. 215, pp. 108901-108901
Open Access | Times Cited: 20
Gene therapy for Leber hereditary optic neuropathy
Marco Battista, Valério Carelli, Leonardo Bottazzi, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 521-528
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top